Vipul Khetarpaul, MD
Vascular Surgery · Saint Louis, MONPI 1972730547
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Penumbra, Inc. at 45.6% of the total. 2025 is the largest year on record at $10,858, more than ten times the $862 reported in 2019.
Across 182 payments — averaging $125.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$10K
- Medtronic$6K
- W. L. Gore & Associates, Inc.$2K
- Elite Orthopedics, LLC$1K
- Shockwave Medical, Inc$780
- Silk Road Medical, Inc.$532
- plus $2K from 24 others
Across 92 payments — averaging $3765.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$208K
- Inari Medical, Inc.$76K
- Penumbra, Inc.$26K
- Cagent Vascular Inc$25K
- Angiodynamics, Inc.$11K
What the payments were for
- Speaking & faculty fees$8,80039%
- Travel & lodging$2,73012%
- Food & beverage$10,07444%
- Education$1,2005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 19 | $10,399 |
| Medtronic(2 entities) | 53 | $5,834 |
| W. L. Gore & Associates, Inc. | 51 | $1,596 |
| Elite Orthopedics, LLC | 1 | $1,200 |
| Shockwave Medical, Inc | 11 | $780 |
| Silk Road Medical, Inc. | 5 | $532 |
| Inari Medical, Inc. | 4 | $382 |
| Boston Scientific | 3 | $352 |
| Veryan Medical Incorporated | 4 | $351 |
| Asahi Intecc USA, Inc. | 3 | $275 |
| Abbott | 2 | $191 |
| Surmodics, Inc. | 1 | $118 |
| Integra Lifesciences Corporation | 1 | $112 |
| Inspiremd Ltd | 1 | $96 |
| Hydrofera LLC | 1 | $79 |
| Bard Peripheral Vascular, Inc. | 3 | $70 |
| Cook Medical LLC | 2 | $53 |
| Kerecis Limited | 2 | $50 |
| Johnson & Johnson(2 entities) | 3 | $47 |
| Bolton Medical Inc | 2 | $42 |
| Lemaitre Vascular, Inc. | 1 | $40 |
| Philips North America LLC | 1 | $36 |
| Acera Surgical, Inc. | 1 | $36 |
| Cardiovascular Systems Inc. | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $23 |
| Acell, Inc. | 1 | $21 |
| Biotronik Inc. | 1 | $19 |
| Medical Device Business Services, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $17 |
| Davol Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$7,788
- RUBY Coil$1,838
- IN.PACT Admiral$1,747
- TurboHawk$1,744
- Abre$674
- ENROUTE Transcarotid Neuroprotection System$629
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$603
- FLOWTRIEVER CATHETER, S$523
- Penumbra System$498
- ENROUTE Transcarotid Stent$474
- GORE VIABAHN Endoprosthesis$415
- Indigo$295
- HawkOne$254
- Valiant Captivia$235
- GORE VIABAHN VBX Balloon Expandable Endo$230
- GENERAL VASCULAR INTERVENTION$168
- BioMimics$164
- ESPRIT$163
- CT THROMBECTOMY SYSTEM KIT$163
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$155
How this compares
$22,803 in reported general payments places this provider in the 75th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 13 | $14,814 |
| Enoxaparin Sodium | 18 | $893 |
| ClopidogrelClopidogrel Bisulfate | 46 | $264 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $47 | $14,81413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 92 vascular surgery providers in Missouri.
Other vascular surgery in Saint Louis
- Jeffrey JimSaint Louis$1.2M
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
- John OhmanSaint Louis$113K
- Patrick GeraghtySaint Louis$65K
- Nathan DrozSaint Louis$38K
- Mohamed ZayedSaint Louis$30K
- Zachary WankenSaint Louis$18K
- Matthew SmedsSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.